{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T23:37:24Z","timestamp":1719877044188},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,4,11]],"date-time":"2007-04-11T00:00:00Z","timestamp":1176249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1007\/s12028-007-0040-x","type":"journal-article","created":{"date-parts":[[2007,5,14]],"date-time":"2007-05-14T08:32:44Z","timestamp":1179131564000},"page":"136-139","source":"Crossref","is-referenced-by-count":7,"title":["Utilization of recombinant activated factor VII for intracranial hematoma evacuation in coagulopathic nonhemophilic neurosurgical patients with normal international normalized ratios"],"prefix":"10.1007","volume":"7","author":[{"suffix":"III","given":"Shearwood","family":"McClelland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Kyung","family":"Won","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelius H.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,4,11]]},"reference":[{"key":"40_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1385\/NCC:1:1:19","volume":"1","author":"ME Fewel","year":"2004","unstructured":"Fewel ME, Park P. The emerging role of recombinant-activated factor VII in neurocritical care. Neurocrit Care 2004;1:19\u201329","journal-title":"Neurocrit Care"},{"issue":"1 Suppl","key":"40_CR2","first-page":"55","volume":"104","author":"M Hartmann","year":"2006","unstructured":"Hartmann M, Sucker C, Messing M. Recombinant activated factor VII in the treatment of near-fatal bleeding during pediatric brain tumor surgery. Report of two cases and review of the literature. J Neurosurg 2006;104(1 Suppl):55\u20138","journal-title":"J Neurosurg"},{"key":"40_CR3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/00008506-200310000-00008","volume":"15","author":"D Karadimov","year":"2003","unstructured":"Karadimov D, Binev K, Nachkov Y, Platikanov V. Use of activated recombinant Factor VII (NovoSeven) during neurosurgery. J Neurosurg Anesthesiol 2003;15:330\u20132","journal-title":"J Neurosurg Anesthesiol"},{"key":"40_CR4","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3171\/jns.2003.98.4.0737","volume":"98","author":"J Lin","year":"2003","unstructured":"Lin J, Hanigan WC, Tarantino M, Wang J. The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings. J Neurosurg 2003;98:737\u201340","journal-title":"J Neurosurg"},{"key":"40_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1227\/01.NEU.0000068830.54968.A8","volume":"53","author":"P Park","year":"2003","unstructured":"Park P, Fewel ME, Garton HJ, Thompson BG, Hoff JT. Recombinant activated factor VII for the rapid correction of coagulopathy in nonhemophilic neurosurgical patients. Neurosurgery. 2003;53:34\u20139","journal-title":"Neurosurgery"},{"key":"40_CR6","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1227\/01.NEU.0000180816.80626.C2","volume":"57","author":"B Roitberg","year":"2005","unstructured":"Roitberg B, Emechebe-Kennedy O, Amin-Hanjani S, Mucksavage J, Tesoro E. Human recombinant factor VII for emergency reversal of coagulopathy in neurosurgical patients: a retrospective comparative study. Neurosurgery 2005;57:832\u20136","journal-title":"Neurosurgery"},{"key":"40_CR7","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1227\/01.NEU.0000179915.74429.b2","volume":"57","author":"DJ Powner","year":"2005","unstructured":"Powner DJ, Hartwell EA, Hoots WK. Counteracting the effects of anticoagulants and antiplatelet agents during neurosurgical emergencies. Neurosurgery 2005;57:823\u201331","journal-title":"Neurosurgery"},{"key":"40_CR8","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.ccc.2005.04.001","volume":"21","author":"TM Enomoto","year":"2005","unstructured":"Enomoto TM, Thorborg P. Emerging off-label uses for recombinant activated factor VII: grading the evidence. Crit Care Clin 2005;21:611\u201332","journal-title":"Crit Care Clin"},{"key":"40_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1385\/NCC:2:3:263","volume":"2","author":"DL Brody","year":"2005","unstructured":"Brody DL, Aiyagari V, Shackleford AM, Diringer MN. Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage. Neurocrit Care 2005;2:263\u20137","journal-title":"Neurocrit Care"},{"key":"40_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/10245330310001594252","volume":"8","author":"SM Dunkley","year":"2003","unstructured":"Dunkley SM, Mackie F. Recombinant factor VIIa used to control massive haemorrhage during renal transplantation surgery; vascular graft remained patent. Hematology 2003;8:263\u20134","journal-title":"Hematology"},{"key":"40_CR11","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1111\/j.1537-2995.2004.04080.x","volume":"44","author":"WY Huang","year":"2004","unstructured":"Huang WY, Kruskall MS, Bauer KA, Uhl L, Shaz BH. The use of recombinant activated factor VII in three patients with central nervous system hemorrhages associated with factor VII deficiency. Transfusion 2004;44:1562\u20136","journal-title":"Transfusion"},{"key":"40_CR12","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1097\/01.ta.0000239261.48022.f1","volume":"61","author":"PI Johansson","year":"2006","unstructured":"Johansson PI, Eriksen K, Alsbjorn B. Rescue treatment with recombinant factor VIIa is effective in patients with life-threatening bleedings secondary to major wound excision: a report of four cases. J Trauma 2006;61:1016\u20138","journal-title":"J Trauma"},{"key":"40_CR13","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/0310057X0303100418","volume":"31","author":"MA Lucey","year":"2003","unstructured":"Lucey MA, Myburgh JA. Recombinant activated factor VII for exsanguinating haemorrhage post bilateral lung transplantation for extra-corporeal lung support-dependent respiratory failure. Anaesth Intensive Care 2003;31:465\u20139","journal-title":"Anaesth Intensive Care"},{"key":"40_CR14","first-page":"1697","volume":"50","author":"AL Mindikoglu","year":"2003","unstructured":"Mindikoglu AL, Anantharaju A, George M, Leone N, Bejna J, Van Thiel DH. Splenic embolization in a Jehovah\u2019s Witness: role of recombinant human factor VIIa. Hepatogastroenterology 2003;50:1697\u20139","journal-title":"Hepatogastroenterology"},{"key":"40_CR15","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/01.PCC.0000123546.78900.67","volume":"5","author":"M Pychynska-Pokorska","year":"2004","unstructured":"Pychynska-Pokorska M, Moll JJ, Krajewski W, Jarosik P. The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. Pediatr Crit Care Med 2004;5:246\u201350","journal-title":"Pediatr Crit Care Med"},{"key":"40_CR16","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s00404-002-0409-1","volume":"268","author":"S Segal","year":"2003","unstructured":"Segal S, Shemesh IY, Blumenthal R, Yoffe B, Laufer N, Ezra Y, Levy I, Mazor M, Martinowitz U. Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa). Arch Gynecol Obstet 2003;268:266\u20137","journal-title":"Arch Gynecol Obstet"},{"key":"40_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.2310\/6670.2006.00004","volume":"14","author":"WA Tawfick","year":"2006","unstructured":"Tawfick WA, Tawfik S, Hynes N, Mahendran B, Sultan S. Critical bleeding in vascular surgery: expanding the indication of recombinant activated factor VII. Vascular 2006;14:32\u20137","journal-title":"Vascular"},{"key":"40_CR18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1161\/01.STR.0000149628.80251.b8","volume":"36","author":"SA Mayer","year":"2005","unstructured":"Mayer SA, Brun NC, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T. Europe\/AustralAsia NovoSeven ICH Trial Investigators. Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage. Stroke 2005;36:74\u20139","journal-title":"Stroke"},{"key":"40_CR19","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1056\/NEJMoa042991","volume":"352","author":"SA Mayer","year":"2005","unstructured":"Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T. Recombinant activated factor VII intracerebral hemorrhage trial investigators. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005;352:777\u201385","journal-title":"N Engl J Med"},{"key":"40_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1365-2516.2005.01098.x","volume":"11","author":"KG Putnam","year":"2005","unstructured":"Putnam KG, Bohn RL, Ewenstein BM, Winkelmayer WC, Avorn J. A cost minimization model for the treatment of minor bleeding episodes in patients with haemophilia A and high-titre inhibitors. Haemophilia 2005;11:261\u20139","journal-title":"Haemophilia"},{"key":"40_CR21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1001\/jama.295.3.293","volume":"295","author":"KA O\u2019Connell","year":"2006","unstructured":"O\u2019Connell KA, Wood JJ, Wise RP, Lozier JN, Braun MM. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA 2006;295:293\u20138","journal-title":"JAMA"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-007-0040-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12028-007-0040-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-007-0040-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-007-0040-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T23:27:31Z","timestamp":1581982051000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12028-007-0040-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,11]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["40"],"URL":"https:\/\/doi.org\/10.1007\/s12028-007-0040-x","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,11]]}}}